Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Elites $5 billion drug in severe shortage.
Approval in few months will catapult us near DollarLand !
It is up from .03 cents. Duh. Continues to build support levels and trend upward. More than double from .08 when you were "frustrated". And there is much more to go with our current pipeline. Not sure if you noticed but it is way past .15 cents, which was your long-awaited exit point.
Any little credibility you ever had is buried back below .15 cents.
Why isn’t the stock price reflecting all of this good.
I don’t bet my life savings on a stock. I bet what I can lose if things go wrong, I will be fine. GLtU
If true, why doesn’t someone step up and buy them now
I've been telling people for a long time that it's the best investment I've seen. Outside of an act of God, hurricane or something they are just going to keep making more drugs. It's really not complicated.
Where's their overhang? Cash flow a little but now they have 20m working capital. Account receivables catching up.
Debt is basically their mortgage and the low rate NJ stuff which is like a couple million they pay on.
Most of these companies are servicing a ton of debt. Which means your margins are lower which means you can't be as competitive.
Probably more frustrating trying to remember all the passwords to all your IDs.
It's been manipulated for a long time. As you can see by the overseas hired hands that work this board, someone needs the stock cheap. You can debate the why, but you can't debate the company.
PE has been looking backwards. But we reached critical mass. Now it's just printing money. Not saying manufacturing drugs is easy. It's obviously complex. But if you can do it, the way Elite can and have the manufacturing space (just doubled) you can basically pick what you want to make the most money on.
Basically an interest free loan. Paid back with reverse interest. It's funny how this is still OTC. And may be when it's sold. That's another debate. But all the drugs are in your local pharmacy and you know the names of most of them. Even just an average person knows them. Billion dollar drugs. Crazy the story being told here.
I agree that Nasrat has done a good job. Just frustrated with the past 12 of the 13 years.
I don't know how to read Prasco. It's great revenue. My question is always on how they figure out quota. Prasco has a large reach
That's a big one. $5 billion dollar drug pending approval. Also in shortage I believe. Lol
Question for the board - what was Nasrat talking about when he was guessing on annual revenue. What was he so embarrassed about ? What was he talking about with Carter. Just seemed odd
I don’t think I’ll be too worried about that. My post are not insulting anyone. There’s no profanity. They’re just my opinion about elite. Again, opinion which I am entitled to do. This is a board to discuss stocks after all. No one should ever buy or sell based on anything that is said on this or any other message board. Especially nothing that I ever say as again, just sharing my opinion.
Fine with that. I got millions of shares so either way I win. I cannot lose!
Sure, unless you are sent back to IHub jail for violating site rules, terms and conditions. Can't 'post as needed' from there. 🤔🤣🛑 Next time is likely a permanent ban.
I say we hit .253 before we hit the143. Loser buys the first bottle of Dom Perignom at the party you hold in your suite in Vegas.
Still not convinced. They said the .123 gap was not going to be hit and guess what…. It hit it…even with the .17 support at the time.
I have as at right about $1.10.
But I am ommitting the unknown unknowns. Meaning over this time, what other drugs are in development and will be trialed and submitted.
I am basing this on what I know today
Nasrat is like a duck. Really calm on the surface but the feet are moving fast underneath. No hype. No fluff. Just growing the business. Revenue parabolic YOY.
Minimum buyout price of $ELTP should be $1.65. MINIMUM.
Vyvanse approval imminent - another $5 billion dollar drug for ELTP to sell.
Nasrat is an attorney and has shown hesitation to fight in the opioid space. If he feels confident fighting Purdue at this time, he must have an excellent reason. All logic supports this.
Estimates for Prasco revenue? I say at least another $12 million per year. Have to add that to valuation.
We should do 10% market penetration of the new drugs. That should be another $100 million in revenue this year.
Nasrat is the greatest CEO!! Just acquired a billion dollar drug pipeline for $900k minus inflation - true cost was about $600k.
Huge revenue growth incoming. This stock is going to pop!!!
PE ratio is too low for a company with this much upside!!
Man this is the best stock on the OTC!!!
In honor of all the paid bashers, let's give a big shout out to Nasrat. Incredible CEO able to deliver excellent returns for long shareholders.
In July 2016 there was a GAP at .25. I think it is more likely that gap will be filled before your fall into the GAP .143 prediction. Check it out.
Regarding technical analysis, the stock has held above .19 since July 18 so that appears to be the current support level.
I am saying most GAPS get touched unless a game changing news happens. I buy all the time above the GAPs but I leave a lot of $$$ ready just in case it hits it. The GAP stands at .143. All ELTP gaps have been hit since the company was founded!!
Why aren't you allowed to say what drugs are pending launch now and if the market value of the drugs is over a billion dollars.
A) you don't know
B) you aren't allowed to say
C) both A and B
Why are you working so hard today? Do you even know?
I do appreciate your posts by the way. They seem to add value. Thanks
Let’s be honest
Has Nasrat been ceo for 13 years. Yes
Has the stock gone up some - yes
Did Nasrat follow Diane’s advice, a secretary, and utilize LPC to get the float to over a billion sharwes. Yes
Did Nasrat nasdaq soon in 2017 and numerous times after that - yes
Are we on the Nasdaq - no
Did Nasrat say he was unwinding MIkAh - yes but can’t validate
Did he unwind MIKAH - no
Did Nasrat say dollarland - yes
Are we at a dollar - hell no.
Read the transcripts I did
No thanks. I will continue to post as needed. Thanks
Some people that obviously lost money here and are very touchy. I post about business and that’s all. Nothing personal. No gap BS. No I’m loading up with more BS. No nonsense. Feel free to reply but don’t cry about spilled milk. You lost money. So be it.
What do you mean “Our Shares” I thought you sold at $0.15. Why are you here. Keep your word and just leave.
Damn, how long did it take to remember this password to this fake ID. 13 years. Jerry says get a better job.
Shortages: Elites future looks bright
Perfect storm is a brewing
FDA shortage link for Adderall:
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet&st=c&tab=tabs-1
FDA shortage link for Vyvance
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lisdexamfetamine%20Dimesylate%20Capsule&st=c
FDA shortage link for Concerta
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release&st=c
FDA shortage link for Naltrexone
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Naltrexone%20Hydrochloride%20Tablet&st=c
FDA shortage link for Methotrexate
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methotrexate%20Sodium%20Tablet&st=c
Bullish
BULLISH
It's funny. They literally aren't allowed to say. I do believe they probably may not know. Ask them anything about what the company is doing and they aren't allowed to answer. It's like some weird kryptonite. Like vampires and crosses.
Ask them the market value of the drugs. That's always fun too. Lol
X. $0.0269
X. $0.03
X. $0.04
X. $0.05
X. $0.06
X. $0.07
X. $0.08
X. $0.09
X. $0.10
X. $0.11
X. $0.12
X. $0.13
X. $0.14
X. $0.15
X. $0.16
X. $0.17
X. $0.18
X. $0.19
_. $0.20
_. $0.21
US Antibiotics in Tennessee. Makes Amoxicillin
Can’t open it. It’s not elite, is it
It’s always soon - like Nasrat said in 2017. Getting on the. Nasdaq soon.
I don't know if this link will open unless you are a subscriber to WSJ but the headline is noteworthy.
https://www.wsj.com/health/pharma/america-is-running-out-of-generic-drugmakers-another-one-is-on-the-brink-dbd8bb17?mod=djem10point
13 years later by the way. Why does no one acknowledge that
LOL. How much is hundred invested in ELTP worth when Nsrat started vs QqQ.
Nasrat made money. Don’t get confused
Just my opinion
It’s about making money. That’s all. All the non sense about Goats, Gap, it’s about to get real, dollarland, no one can stop us - means nothing. We needed him to have a great CC. To be a leader that showed that he can take us to the next level. I just don’t hear that. My opinion
I’m sorry but repeating the same is not new. It’s just the same old stuff. Nasrat needs to either do something big. Resign , get a new ceo or sell the company. I’d like our shares back as well
Followers
|
966
|
Posters
|
|
Posts (Today)
|
80
|
Posts (Total)
|
404285
|
Created
|
03/24/09
|
Type
|
Free
|
Moderators jimr1717 mrwrn2010 NASDAQ2020 IB_ namtae Dr JoeBarducci |
Senior Moderator: IB_
Posted: 7/02/2024
________________________________________________________________________________________________________________
Elite Pharmaceuticals, Inc. |
Website | Location | Employees | Facility | CEO |
www.elitepharma.com | Northvale, New Jersey | 64 | 85,000 sq ft | Nasrat Hakim |
Products & Pipeline | ||||
Drug | Market Size | Status | Competitors | Marketed By |
Adderall IR | 389.8 M | On Market | 15 | Elite |
Adderall XR | 1.56 B | On Market | 10 | Elite & Prasco |
Dantrolene | 6.3 M | On Market | 2 | Elite |
Isradipine | 5.5 M | On Market | 1 | Elite |
Loxapine | 5 M | On Market | 2 | Elite |
Phendimetrazine | 4.5 M | On Market | 4 | Elite |
Trimipramine | 2 M | On Market | 1 | Elite |
Naltrexone | 16 M | On Market | 5 | Precision Dose |
Phentermine Capsules | 7.5 M | On Market | 6 | Precision Dose |
Phentermine Tablets | 40 M | On Market | 8 | Precision Dose |
Vigabatrin | 233.7 M | On Market | 13 | Pyros |
Doxycycline | 85 M | Approved (Discontinued) | 9 | ---------- |
Tylenol with Codeine | 45 M | Approved | 5 | ---------- |
Dopamine Agonist | 12 M | Filed with FDA - 22 Dec 2022 | ---------- | ---------- |
Methotrexate | 64.3M | Approved - 16 May 2024 | 8 | Elite |
Percocet | 500 M | Approved | --------- | ---------- |
Norco | 477 M | Approved | --------- | ---------- |
Methadone | 30 M | Approved | --------- | ---------- |
OxyContin | 720 M | Filed with FDA - 17 Aug 2023 | ---------- | ---------- |
Vyvanse | 5.1 B | Filed with FDA - 21 Dec 2023 | 14 | ---------- |
Concerta | 1.16 B | In Development (Final Stages) | 9 | ---------- |
Financials | ||||
Fiscal Year | Revenue | Change | Net Income | Change |
2019 | 7,568,508 | ---------- | (9,279,321) | ---------- |
2020 | 17,994,639 | +137.76% | (2,240,351) | +75.86% |
2021 | 25,380,749 | +41.05% | 5,088,421 | +327.13% |
2022 | 32,262,117 | +27.11% | 8,898,245 | +74.87% |
2023 | 34,155,114 | +5.87% | 3,561,846 | -59.97% |
2024 | 56,625,128 | +65.79% | 20,108,631 | +464.56% |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |